Drug intelligence / Profile preview

OvaCyst

Development stage
Unknown
Lead developer
Bimeda
Modality
Peptides
Administration
Intramuscular, Intravenous
01

Overview

OvaCyst is a veterinary injectable formulation of the gonadotropin-releasing hormone (GnRH) analog gonadorelin diacetate tetrahydrate, containing 50 mcg/mL gonadorelin, used in cattle for reproductive management. By mimicking endogenous hypothalamic GnRH, gonadorelin stimulates the anterior pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), thereby inducing ovulation and luteinization of follicular ovarian cysts and enabling synchronization of estrous cycles when used in timed artificial insemination (FTAI) protocols with prostaglandin analogs such as cloprostenol sodium.[1][7] It is supplied as a sterile intramuscular or intravenous solution for use by licensed veterinarians in dairy and beef cows for treatment of cystic ovaries and for estrus synchronization programs.[1]

Brand names
OvaCyst
02

Targets

GnRHR (Gonadotropin-releasing hormone receptor)LHCGR (Luteinizing hormone/choriogonadotropin receptor)

Beyond the preview

Go deeper on OvaCyst.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OvaCyst.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call